Impact of sarcopenic obesity on long-term clinical outcomes after ST-segment elevation myocardial infarction
Atherosclerosis Sep 01, 2021
Sato R, Okada K, Akiyama E, et al. - The results showed that low appendicular skeletal muscle index (ASMI) with high visceral to subcutaneous (V/S) fat ratio, or so-called sarcopenic obesity, was correlated with poor prognosis after ST-segment elevation myocardial infarction (STEMI), especially in younger-age patients. The data indicated that combined evaluation of skeletal muscle with abdominal fat distribution may help stratify the risk among patients with STEMI, rather than each component alone.
Researchers analyzed ASMI and V/S fat ratio using dual-energy x-ray absorptiometry and abdominal computed tomography in 303 patients with STEMI.
The primary endpoint occurred in 67 patients during a median follow-up of 3.9 years. A significantly lower event-free survival rate was found in patients with sarcopenic obesity (SO) pattern compared with those without (p=0.006 by log-rank).
Remarkably, this trend was particularly prominent in the younger age group (p <0.001), but not significant in the older age group (p=0.38) when stratified by median age (67 years).
The multivariate analysis demonstrated that patients with SO pattern had a 2.97 (1.10–7.53) fold higher risk for primary endpoints compared with those without in the younger age group.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries